Our previous study indicated that LWWL could attenuate hepatic fibrosis via the modulation of TGF-β1 and NF-κB signaling pathways in rat models, based on bile duct ligation (BDL)- and CCl4-induced hepatic fibrosis (Liu et al., 2018a; Liu et al., 2018b). The gene discussed is NFKB1; the disease is Hepatic fibrosis.